# EDGAR Filing Document

**Accession Number:** 0002098235
**File Stem:** 0002098235-25-000003
**Filing Date:** 2025-11
**Character Count:** 7040
**Document Hash:** 5260a00995f604ea74dfb10c27d3ed58
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002098235-25-000003.hdr.sgml**: 20251125

**ACCESSION NUMBER**: 0002098235-25-000003

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251116

**FILED AS OF DATE**: 20251125

**DATE AS OF CHANGE**: 20251125

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Durocher John
- **CENTRAL INDEX KEY:** 0002098235

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34674
- **FILM NUMBER:** 251522827

**MAIL ADDRESS:**
- **STREET 1:** C/O CALIX, INC.
- **STREET 2:** 3155 OLSEN DRIVE, SUITE 450
- **CITY:** SAN JOSE
- **STATE:** CA
- **ZIP:** 95128
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CALIX, INC
- **CENTRAL INDEX KEY:** 0001406666
- **STANDARD INDUSTRIAL CLASSIFICATION:** COMMUNICATION SERVICES, NEC [4899]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 680438710
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3155 OLSEN DRIVE, SUITE 450
- **CITY:** SAN JOSE
- **STATE:** CA
- **ZIP:** 95117
- **BUSINESS PHONE:** 408-514-3000

**MAIL ADDRESS:**
- **STREET 1:** 3155 OLSEN DRIVE, SUITE 450
- **CITY:** SAN JOSE
- **STATE:** CA
- **ZIP:** 95117

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CALIX NETWORKS INC
- **DATE OF NAME CHANGE:** 20070713

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Durocher John<br><sub>(Last) (First) (Middle)</sub><br>C/O CALIX, INC.<br>3155 OLSEN DRIVE, SUITE 450<br><sub>(Street)</sub><br>SAN JOSE, CA 95117<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>CALIX, INC [ (CALX) ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-11-16 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_COO_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 1928 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Option (right to buy) | <sup>(1)</sup> | 2033-03-24 | Common Stock | 200000 | $51.83 | D |  |
| Stock Option (right to buy) | <sup>(2)</sup> | 2033-03-24 | Common Stock | 42555 | $51.83 | D |  |
| Stock Option (right to buy) | <sup>(3)</sup> | 2034-02-08 | Common Stock | 107775 | $34.26 | D |  |
| Stock Option (right to buy) | <sup>(4)</sup> | 2034-02-08 | Common Stock | 56350 | $34.26 | D |  |
| Stock Option (right to buy) | <sup>(5)</sup> | 2035-01-31 | Common Stock | 195000 | $39.68 | D |  |
| Stock Option (right to buy) | <sup>(6)</sup> | 2035-01-31 | Common Stock | 195000 | $39.68 | D |  |

---

### Footnotes:

(1) 25% of the shares subject to the stock option grant vested on March 24, 2024, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to the reporting person's service through each applicable vesting date. As of November 25, 2025, 125,000 shares subject to the option grant are fully vested and exercisable.

(2) 25% of the shares subject to the stock option grant vested on March 24, 2024, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to the reporting person's service through each applicable vesting date. As of November 25, 2025, 26,597 shares subject to the option grant are fully vested and exercisable.

(3) 25% of the shares subject to the stock option grant vested on February 8, 2025, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to the reporting person's service through each applicable vesting date. As of November 25, 2025, 47,151 shares subject to the option grant are fully vested and exercisable.

(4) 25% of the shares subject to the stock option grant vested on February 8, 2025, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to the reporting person's service through each applicable vesting date. As of November 25, 2025, 17,622 shares subject to the option grant are fully vested and exercisable.

(5) 25% of these stock options will vest on the first anniversary of the grant date. Thereafter, the remainder of these stock options will vest quarterly in substantially equal installments over the next 36 months, subject to Reporting Person's continued service through each vesting date.

(6) The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from January 31, 2026, subject to the reporting person's continued employment with Calix through the applicable vesting dates.

**Signature:** /s/ Tom Gemetti as Attorney-in-Fact for John Durocher  
**Date:** 2025-11-25

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**